Related Experiment Video
Updated: Jan 24, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Reconciling environment-mediated metabolic heterogeneity with the oncogene-driven cancer paradigm in precision
Catherine Vander Linden1, Cyril Corbet1
1Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), UCLouvain, 57 Avenue Hippocrate, B1.57.04, B-1200 Brussels, Belgium.
Abstract:
Precision oncology is the practice of matching one therapy to one specific patient, based on particular genetic tumor alterations, in order to achieve the best clinical response. Despite an expanding arsenal of targeted therapies, many patients still have a poor outcome because tumor cells show a remarkable capacity to develop drug resistance, thereby leading to tumor relapse. Besides genotype-driven resistance mechanisms, tumor microenvironment (TME) peculiarities strongly contribute to generate an intratumoral phenotypic heterogeneity that affects disease progression and treatment outcome. In this Review, we describe how TME-mediated metabolic heterogeneities actively participate to therapeutic failure. We report how a lactate-based metabolic symbiosis acts as a mechanism of adaptive resistance to targeted therapies and we describe the role of mitochondrial metabolism, in particular oxidative phosphorylation (OXPHOS), to support the growth and survival of therapy-resistant tumor cells in a variety of cancers. Finally, we detail potential metabolism-interfering therapeutic strategies aiming to eradicate OXPHOS-dependent relapse-sustaining malignant cells and we discuss relevant (pre)clinical models that may help integrate TME-driven metabolic heterogeneity in precision oncology.
Insights
Precision oncology faces challenges from drug resistance. The tumor microenvironment (TME) drives resistance through metabolic changes, like lactate symbiosis and oxidative phosphorylation (OXPHOS), impacting treatment outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Metabolic Research
Background:
- Precision oncology aims to tailor treatments to individual genetic profiles for optimal response.
- Drug resistance and tumor relapse remain significant challenges, limiting the efficacy of targeted therapies.
- The tumor microenvironment (TME) significantly influences tumor heterogeneity and treatment outcomes, beyond genetic factors.
Purpose of the Study:
- To review the role of TME-mediated metabolic heterogeneities in therapeutic failure.
- To elucidate how metabolic symbiosis and oxidative phosphorylation (OXPHOS) contribute to adaptive resistance.
- To discuss metabolism-interfering strategies for eradicating therapy-resistant cancer cells.
Main Methods:
- Literature review focusing on TME-mediated metabolic adaptations in cancer.
- Analysis of mechanisms of adaptive resistance, including lactate symbiosis and OXPHOS.
- Exploration of preclinical models for TME-driven metabolic heterogeneity.
Main Results:
- TME-driven metabolic heterogeneities actively contribute to treatment failure in precision oncology.
- Lactate-based metabolic symbiosis serves as an adaptive resistance mechanism against targeted therapies.
- Oxidative phosphorylation (OXPHOS) supports the survival and growth of therapy-resistant tumor cells across various cancers.
Conclusions:
- Targeting TME-mediated metabolic pathways, particularly OXPHOS, offers a promising strategy to overcome drug resistance.
- Integrating TME-driven metabolic heterogeneity into precision oncology frameworks is crucial for improving patient outcomes.
- Further research and development of metabolism-interfering therapies are needed to combat relapse-sustaining cancer cells.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
What is Metabolism?
Uncertainty in Measurement: Accuracy and Precision
Receptor-mediated Endocytosis
Accuracy and Precision
Gene-Environment Interactions

